Xeris Biopharma Holdings Inc. buy Oppenheimer Holdings Inc.
Start price
29.10.25
/
50%
€8.51
Target price
29.10.26
€15.45
Performance (%)
-11.53%
Price
19.08.26
€7.52
Summary
This prediction is currently active. The prediction for Xeris Biopharma Holdings Inc. disappoints with a performance of -11.53%. This prediction currently runs until 29.10.26. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Xeris Biopharma Holdings Inc. | 3.551% | 3.551% |
| iShares Core DAX® | -1.586% | 5.028% |
| iShares Nasdaq 100 | -4.148% | -0.125% |
| iShares Nikkei 225® | -6.302% | 0.528% |
| iShares S&P 500 | -3.225% | 0.470% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma (NASDAQ:XERS) was given a new $18.00 price target on by analysts at Oppenheimer Holdings, Inc.. They now have an "outperform" rating on the stock.
Ratings data for XERS provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€6.66
12.11.25
12.11.25
€15.55
12.11.26
12.11.26
13.06%
19.08.26
19.08.26
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€4.45
09.05.25
09.05.25
€6.24
09.05.26
09.05.26
22.54%
10.05.26
10.05.26
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€2.04
28.03.24
28.03.24
€4.62
28.03.25
28.03.25
154.90%
29.03.25
29.03.25